The effect of memantine on fatigue in patients with Multiple Sclerosis
Phase 3
- Conditions
- Multiple Sclerosis.Multiple sclerosis
- Registration Number
- IRCT20240118060725N1
- Lead Sponsor
- Qazvin University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Age 20-50 years
EDSS between 0-5
Relapsing-Remitting MS
Grade 3 or 4 fatigue according to the questionnaire?
Exclusion Criteria
Use of Modafinil, Ritalin or Amantadine
History of seizures or kidney disease
Taking selective serotonin reuptake inhibitor (SSRI)
Recent attack within the last 3 months
Use of Dalfira
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Examining the degree of fatigue based on the Modified Fatigue Impact Scale questionnaire. Timepoint: Comparison of fatigue before and 3 months after starting memantine and placebo. Method of measurement: Modified Fatigue Impact Scale questionnaire.
- Secondary Outcome Measures
Name Time Method